Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $298M Series B (Nov 2025) at $2.5B valuation. Largest-ever longevity raise. 160+ lab tests + full-body MRI. Medical Intelligence AI model launched.
Function Health is a consumer preventive diagnostics company offering 160+ laboratory tests plus a $499 full-body MRI scan, all direct-to-consumer with AI-powered health intelligence layered on top. The company raised $298 million in Series B financing in November 2025 at a $2.5 billion valuation — the largest private fundraise in the longevity and preventive health space in history. The Medical Intelligence generative AI model, launched alongside the round, personalizes health guidance based on longitudinal biomarker data accumulated across repeat testing cycles.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.